Therapy by synthetic antimicrobial drugs is increasingly becoming limited by microbial resistance. As a possible remedy, antimicrobials from medicinal plants are being explored. The objective of this work was to compare the activities of extracts of Terminalia neotaliala capuron, oxacillin, and fluconazole on the in vitro growth of Staphylococcus aureus ATCC and Aspergillus niger. The evaluation was made by incorporating the hydroalcoholic extract of the plant (Combretaceae), oxacillin, and fluconazole using the oblique double dilution method with Sabouraud agar into wells cut into Petrie dishes. After 48 hours of incubation at 30⁰ C, zones of inhibition were measured. Oxacillin had a greater zone of inhibition than the plant extract on Staphylococcus aureus ATCC for all concentrations. The zone of inhibition for fluconazole was lower than that of the extract on Aspergillus niger for the concentrations of 200 mg/mL and 100 mg/mL. The hydroethanolic extract of Terminalia neotaliala capuron inhibited the growth of Staphylococcus aureus ATCC and Aspergillus niger.
For millennia, man has drawn from his immediate environment the resources necessary for his survival and for his well-being. Even before possessing the use of writing, he could transmit the experience of medicine and all types of natural remedies to finally develop what we now call traditional medicine 1. In many developing countries, called developed countries, herbal medicine has gained popularity 2. Indeed, according to 3, 80% of africans in rural areas use plants as their main source of health care. This enthusiasm is explained by the fact that many diseases are treated satisfactorily and at a lower cost by plants 4. This recourse to traditional medicine is also due to the distrust of populations with respect to synthetic products and especially to the choice to consume healthy organic products grouped under the term "BIOʺ 5. Plants have demonstrated promising pharmacological effects in a wide variety of diseases, such as cancer 6, diabetes 7, and infectious diseases 8. For example, in the field of treatment of infectious diseases, faced with the multiplicity of antimicrobial resistance to existing antibiotics, plants are positioning themselves as true providers of bioactive molecules for pharmaceutical companies 9. Moreover, they constitute an alternative therapeutic approach for the populations of disadvantaged countries. In the socio-economic context of developing countries, the study of plants can lead to obtaining adequate therapeutic responses at affordable costs for often poor populations.
In order to contribute to the revaluation and rational exploitation of these plants and their bioactive substances, Terminalia neotaliala capuron, a combretaceae used in the traditional environment against gastroenteritis, skin conditions, candidiasis, hypertension blood pressure, diabetes, oral diseases 10.
Terminalia neotaliala capuron barks were collected in July 2021 on the campus of the University Felix HOUPHOUET-BOIGNY Cocody (Abidjan; Ivory Coast). The plant was identified at the National Center of Floristics of the said university with the herbarium number UCJ003173.
2.2. Germs UsedStaphylococcus aureus ATCC is a bacterial provided by Pasteur Institute of Cocody (Ivory Coast). Aspergillus niger is a microscopic fungus provided by the mycology service from Medical Sciences department of Felix Houphouet-Boigny University (Abidjan, Ivory Coast).
2.3. ExtractionTerminalia neotaliala capuron stem bark was harvested, cut into small pieces and dried in the sun at a temperature of 25°C. After grinding and rendered into fine powder, the hydroalcoholic extract was prepared. For this purpose, 1L of solvent comprising 70% ethanol and 30% distilled water was added to 100g of the fine plant powder. The whole was homogenized in a blender. After six (6) cycles of homogenization, the homogenate was wrung out in a square of white cloth then filtered successively twice on absorbent cotton and once on Whatman 3mm paper. The filtrate was concentrated (16%) with a Büchi type rotary evaporator.
2.4. Antimicrobial TestsConcentration ranges from 200 mg/mL to 1.56 mg/mL of reason ½ were prepared for the hydroethanol extract, fluconazole and oxacillin. On petri dishes on which beforehand, were seeded separately microbial strains. A quantity of 1mL of each extract was introduced in a well (3mm diameter). The observation was done 48h.
The inhibition diameters were recorded in each petri dish. The results are recorded in the Table 1 and the different cultures Figure 1, Figure 2, Figure 3 and Figure 4.
The choice of the barks of the plant and the activities mentioned is linked to the fact that this part of the plant is traditionally used to treat various gastroenteritis (diarrhea, dysentery) and infectious pathologies 11.
The 70% hydro-ethanolic extract of Terminalia neotaliala capuron bark powder gave a yield of 16%. The yield obtained is linked to the affinity that the secondary metabolites contained in the bark of the trunk of Terminalia neotaliala capuron have for the binary solvent used (Water-ethanol, 30:70, V/V).
This yield is greater than 10.47% obtained by 12 and substantially equal to 15.41% obtained by 13 but lower than 29.08 obtained by 14. All these authors used the bark of the trunk of Terminalia mantaly with the same solvent (Water-ethanol, 30:70, V/V). These differences could be explained by the influence of different abiotic factors (habitat, time of harvest, stage of development, etc.). Indeed, the studies of 15 on the influence of the saponin content of plants by abiotic factors showed that the place and the season of harvest affect the chemical composition and the yield. The yield makes it possible to assess the quantity of extract that can be obtained from the species but does not make it possible to establish a related to therapeutic activity. Also, it makes it possible to consider the quantity of organ to be removed if necessary for a possible similar study. This would make the use of medicinal plants more rational and therefore sustainable for the targeted species.
The antibacterial activities of Terminalia neotaliala capuron extract and oxacillin performed against S. aureus ATCC showed that the extract and the antibiotic inhibited growth in vitro at the different concentrations used. According to the solid medium diffusion method, a substance is considered active when it induces a zone of inhibition with a diameter greater than or equal to 10 mm 16. The S. aureus ATCC strain had inhibition diameters greater than or equal to 10 mm against the plant extract and oxacillin, for all concentrations.
In addition, the better activity of oxacillin observed on the strain of S. aureus ATCC compared to the extract would be explained by the fact that the extract being a totum, another compound could act as an antagonist to the action of the compound in the extract responsible for the antibacterial activity related to therapeutic activity. Also, it makes it possible to consider the quantity of organ to be removed if necessary for a possible similar study. This would make the use of medicinal plants more rational and therefore sustainable for the targeted species.
The antibacterial activities of Terminalia neotaliala capuron extract and oxacillin performed against S. aureus ATCC showed that the extract and the antibiotic inhibited growth in vitro at the different concentrations used. According to the solid medium diffusion method, a substance is considered active when it induces a zone of inhibition with a diameter greater than or equal to 10 mm. The S. aureus ATCC strain had inhibition diameters greater than or equal to 10 mm against the plant extract and oxacillin, for all concentrations.
In addition, the better activity of oxacillin observed on the strain of S. aureus ATCC compared to the extract would be explained by the fact that the extract being a totum, another compound could act as an antagonist to the action of the compound in the extract responsible for the antibacterial activity.
Furthermore, the antifungal activity of Terminalia neotaliala capuron and the antifungal (fluconazole) on Aspergillus niger was compared. The best sensitivity was obtained with the plant extract for concentrations of 200 mg/mL. For concentrations below 100mg/mL the plant extract and fluconazole showed the same inhibition diameter value, i.e. equal to 8mm. The antimicrobial effects of the extract observed could be due to saponins, phenols, alkaloids, flavonoids, triterpenes, tannins and anthraquinone 17. Indeed, these secondary metabolites act on microorganisms by various mechanisms. Tannins bind to proline-rich proteins and interfere with yeast protein synthesis 18. Regarding flavonoids, they act by forming insoluble complexes with the proteins of the cell wall, weakening it 19. As for saponins, they cause the lysis of some membrane and plasma proteins 20. Phenols act by inhibiting and interacting with microbial enzymes 21. As for quinones, they form irreversible complexes with the nucleophilic amino acids of proteins and neutralize their functions 22. They also inhibit the activity of microorganism substrates 23. In addition, other quinones such as anthraquinones inhibit nucleic acid synthesis 24.
It emerges by taking into account only the germs that the extract is more effective on Staphylococcus aureus ATCC than on Aspergillus niger. As for the reference substances, oxacillin is more effective than fluconazole.
At the end this study, financial support to research and pedagogy unity of biochemical of pharmacodynamy, the national center of floristics from department of University Felix HOUPHOUET BOIGNY in Cocody-Abidjan (Ivory Coast) and unit of fundamental Medical Biochemistry of Pasteur institute (in Cocody-Abidjan; Ivory Coast) are gratefully acknowledged.
The author declares no conflict of interest regarding the publication of this article.
[1] | Roumy. V. (2007). Étude phytochimique de plantes amazoniennes d'activité antiplasmodiale, dont Pseudoxandra cuspidata Maas et Tapirira guianensis Aubl. Thèse de Doctorat en Sciences des Agrorcssources option Pharmacognosie. Institut National Polytechnique de Toulouse 195p. | ||
In article | |||
[2] | O.M.S. (2003). Organisation Mondiale de la Santé (O.M.S). Médicaments essentiels et politiques pharmaceutiques:donner un soutien aux pays pour réduire le manque d'accès aux médicaments. Genève: OMS (Rapport annuel 2002), 20 p. | ||
In article | |||
[3] | Patra A., Jha S., & Murthy PN. (2009). Phytochemical and pharmacological potential of Hygrophila spinosa T. Anders. Pharmacognosy Reviews, 3: 330-341. | ||
In article | |||
[4] | Kamanyi A., Dongmo AB. & Bopelet M., 1995. Etude des proprietés hypotensives de l’extrait aqueux et une saponine totale des feuilles de Musanga cecropioides (Cecropiaceae) chez le rat. Revue Medical, Pharmaceutique, Africaine, 9: 107-113. | ||
In article | |||
[5] | Duke JA. (1993). Medicinal plants and the pharmaceutical industry. In New Crops. Edited by Janick J. and Simon J.E. New York; pp.664-669. | ||
In article | |||
[6] | Shirzad M., Kordyazdi R., Shahinfard N. & Nikokar M. (2011). Does royal jelly affect tumor cells. Journal of Herbmed Pharmacology, 2: 45-48. | ||
In article | |||
[7] | Asgary S., Rafieian-Kopaei M., Shamsi F., Najafi S. & Sahebkar A. (2014). Biochemical and histopathological study of the anti-hyperglycemic and anti-hyperlipidemic effects of Cornelian cherry (Cornus mas L.) in alloxan-induced diabetic rats. Journal of Complementary and Integrative Medicine, 11: 63-69. | ||
In article | View Article | ||
[8] | Ngezahayo J., Havyarimana F., Hari L., Stévigny C. & Duez P. (2015). Medicinal plants usedby Burundian traditional healers for the treatment of microbial diseases. Journal of Ethnopharmacology, 15(173): 338-351. | ||
In article | View Article PubMed | ||
[9] | Butler M.S. (2004). The role of natural product chemistry in drug discovery. Journal of Natural Products, 67: 2141-2153. | ||
In article | View Article PubMed | ||
[10] | Rivière C., Nicolas JP., Caradec ML., Désiré O. & Schmitt A. (2005). Les plantes de la région Nord de Madagascar: une approche ethno pharmacologique. Bulletin de la Société Française d’Ethnopharmacologie et de la Société Européenne d’Ethnopharmacologie, 36: 36-50. | ||
In article | |||
[11] | Orwa C., Mutua A., Kindt R., Jamnadas R. & Simons A. (2009): Agroforestree Database:a tree reference and selection guide version 4.0, 5p. www.worldagroforestry.org/af/treedb/ Consulté le 24/05/2012. | ||
In article | |||
[12] | Bolou EKG., Yao K., Agre JD., Nguessan CRD., Zirihi NG. & Djaman JA. (2022). Evaluation of the antifungal powers of five plant species of the genus Terminalia on strains responsible for candidiasis. Journal of Drug Delivery & Therapeutics, 12: 73-76. | ||
In article | View Article | ||
[13] | Abou O., Elisée KK., Vénérer MS., Bi S. & Ibrahim K. (2018). Etude de l’activité antibactérienne d’extraits d’écorce de Terminalia mantaly (Combretaceae) sur la croissance in vitro de huit (8) souches cliniques d’entérobactéries. 6, 101-105. | ||
In article | |||
[14] | Ngouana KT. (2008). Etude de l’activité antifongique de l’écorce de Croton zambesicus sur quelques champignons responsables des mycoses humaines. Mémoire du Diplôme d’Etude Approfondie en Biochimie. Université de Yaoundé I. 65p.² | ||
In article | |||
[15] | Adjou ES. & Soumanou MM. (2013). Efficacité des extraits de plantes dans la lutte contre les moisissures toxinogènes isolées de l’arachide en post-récolte au Bénin. Journal of Applied Biosciences, 70: 5555-5566. | ||
In article | View Article | ||
[16] | Biyiti LF., Meko'o DJL., Tamzc V. & Amvam ZPH. (2004). Recherche de l'activitéantibactérienne de quatre plantes médicinales camerounaises. Pharmacopée et médecine traditionnelle africaine 13: 11-20. | ||
In article | |||
[17] | Yaye GY., Kra MKA., Ackah JAAB. & Djaman AJ. (2011). Évaluation de l’activité antifongique et essai de purification des principes actifs des extraits de Terminalia mantaly (H. Perrier), une combrétacée, sur la croissance in vitro de Candida albicans. Bulletin de la Société Royale des Sciences de Liège, 80: 953‑964. | ||
In article | |||
[18] | Shimada T. (2006). Salivary proteins as a defence against dietary tannins. Journal of Chemical Ecology, 32 (6): 1149-1163. | ||
In article | View Article PubMed | ||
[19] | Marjorie C. (1999). Plant Products as Antimicrobial Agents. Clinical Microbiology, 12: 564-582. | ||
In article | View Article PubMed | ||
[20] | Zablotowicz RM, Hoagland RE & Wagner SC. (1996). Effect of saponins on the growth and activity of rhizosphere bacteria. Advances in Experimental Medicine and Biology, 405: 83-95. | ||
In article | View Article PubMed | ||
[21] | Mason TL. & Wasserman BP. (1987). Inactivation of red beet beta-glucan synthase by native and oxidized phenolic compounds. Phytochemistry, 26: 2197-2202. | ||
In article | View Article | ||
[22] | Stern LJ., Hagerman AE., Steinberg PD. & Mason PK. (1996). Phlorotannin-protein interactions. Journal of Chemical Ecology, 22: 1877-1899. | ||
In article | View Article PubMed | ||
[23] | Cowan M.M, (1999). Plant products as antimicrobial agents. Clinical Microbiology Reviews, 12: 564-582. | ||
In article | View Article PubMed | ||
[24] | Harborne J.B., Baxter H. & Moss G. P. (1999). Phytochemical dictionary. In A handbook of bioactive compounds from plants. London, Taylor & Francis Eds, 27; 869-877. | ||
In article | |||
Published with license by Science and Education Publishing, Copyright © 2023 Ouattara Sitapha, Ahon Gnamien Marcel, Kporou Kouassi Elisée, Bagre Issa, Soro Yédé Débora, Kra Adou Koffi Mathieu and Djaman Allico Joseph
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit
https://creativecommons.org/licenses/by/4.0/
[1] | Roumy. V. (2007). Étude phytochimique de plantes amazoniennes d'activité antiplasmodiale, dont Pseudoxandra cuspidata Maas et Tapirira guianensis Aubl. Thèse de Doctorat en Sciences des Agrorcssources option Pharmacognosie. Institut National Polytechnique de Toulouse 195p. | ||
In article | |||
[2] | O.M.S. (2003). Organisation Mondiale de la Santé (O.M.S). Médicaments essentiels et politiques pharmaceutiques:donner un soutien aux pays pour réduire le manque d'accès aux médicaments. Genève: OMS (Rapport annuel 2002), 20 p. | ||
In article | |||
[3] | Patra A., Jha S., & Murthy PN. (2009). Phytochemical and pharmacological potential of Hygrophila spinosa T. Anders. Pharmacognosy Reviews, 3: 330-341. | ||
In article | |||
[4] | Kamanyi A., Dongmo AB. & Bopelet M., 1995. Etude des proprietés hypotensives de l’extrait aqueux et une saponine totale des feuilles de Musanga cecropioides (Cecropiaceae) chez le rat. Revue Medical, Pharmaceutique, Africaine, 9: 107-113. | ||
In article | |||
[5] | Duke JA. (1993). Medicinal plants and the pharmaceutical industry. In New Crops. Edited by Janick J. and Simon J.E. New York; pp.664-669. | ||
In article | |||
[6] | Shirzad M., Kordyazdi R., Shahinfard N. & Nikokar M. (2011). Does royal jelly affect tumor cells. Journal of Herbmed Pharmacology, 2: 45-48. | ||
In article | |||
[7] | Asgary S., Rafieian-Kopaei M., Shamsi F., Najafi S. & Sahebkar A. (2014). Biochemical and histopathological study of the anti-hyperglycemic and anti-hyperlipidemic effects of Cornelian cherry (Cornus mas L.) in alloxan-induced diabetic rats. Journal of Complementary and Integrative Medicine, 11: 63-69. | ||
In article | View Article | ||
[8] | Ngezahayo J., Havyarimana F., Hari L., Stévigny C. & Duez P. (2015). Medicinal plants usedby Burundian traditional healers for the treatment of microbial diseases. Journal of Ethnopharmacology, 15(173): 338-351. | ||
In article | View Article PubMed | ||
[9] | Butler M.S. (2004). The role of natural product chemistry in drug discovery. Journal of Natural Products, 67: 2141-2153. | ||
In article | View Article PubMed | ||
[10] | Rivière C., Nicolas JP., Caradec ML., Désiré O. & Schmitt A. (2005). Les plantes de la région Nord de Madagascar: une approche ethno pharmacologique. Bulletin de la Société Française d’Ethnopharmacologie et de la Société Européenne d’Ethnopharmacologie, 36: 36-50. | ||
In article | |||
[11] | Orwa C., Mutua A., Kindt R., Jamnadas R. & Simons A. (2009): Agroforestree Database:a tree reference and selection guide version 4.0, 5p. www.worldagroforestry.org/af/treedb/ Consulté le 24/05/2012. | ||
In article | |||
[12] | Bolou EKG., Yao K., Agre JD., Nguessan CRD., Zirihi NG. & Djaman JA. (2022). Evaluation of the antifungal powers of five plant species of the genus Terminalia on strains responsible for candidiasis. Journal of Drug Delivery & Therapeutics, 12: 73-76. | ||
In article | View Article | ||
[13] | Abou O., Elisée KK., Vénérer MS., Bi S. & Ibrahim K. (2018). Etude de l’activité antibactérienne d’extraits d’écorce de Terminalia mantaly (Combretaceae) sur la croissance in vitro de huit (8) souches cliniques d’entérobactéries. 6, 101-105. | ||
In article | |||
[14] | Ngouana KT. (2008). Etude de l’activité antifongique de l’écorce de Croton zambesicus sur quelques champignons responsables des mycoses humaines. Mémoire du Diplôme d’Etude Approfondie en Biochimie. Université de Yaoundé I. 65p.² | ||
In article | |||
[15] | Adjou ES. & Soumanou MM. (2013). Efficacité des extraits de plantes dans la lutte contre les moisissures toxinogènes isolées de l’arachide en post-récolte au Bénin. Journal of Applied Biosciences, 70: 5555-5566. | ||
In article | View Article | ||
[16] | Biyiti LF., Meko'o DJL., Tamzc V. & Amvam ZPH. (2004). Recherche de l'activitéantibactérienne de quatre plantes médicinales camerounaises. Pharmacopée et médecine traditionnelle africaine 13: 11-20. | ||
In article | |||
[17] | Yaye GY., Kra MKA., Ackah JAAB. & Djaman AJ. (2011). Évaluation de l’activité antifongique et essai de purification des principes actifs des extraits de Terminalia mantaly (H. Perrier), une combrétacée, sur la croissance in vitro de Candida albicans. Bulletin de la Société Royale des Sciences de Liège, 80: 953‑964. | ||
In article | |||
[18] | Shimada T. (2006). Salivary proteins as a defence against dietary tannins. Journal of Chemical Ecology, 32 (6): 1149-1163. | ||
In article | View Article PubMed | ||
[19] | Marjorie C. (1999). Plant Products as Antimicrobial Agents. Clinical Microbiology, 12: 564-582. | ||
In article | View Article PubMed | ||
[20] | Zablotowicz RM, Hoagland RE & Wagner SC. (1996). Effect of saponins on the growth and activity of rhizosphere bacteria. Advances in Experimental Medicine and Biology, 405: 83-95. | ||
In article | View Article PubMed | ||
[21] | Mason TL. & Wasserman BP. (1987). Inactivation of red beet beta-glucan synthase by native and oxidized phenolic compounds. Phytochemistry, 26: 2197-2202. | ||
In article | View Article | ||
[22] | Stern LJ., Hagerman AE., Steinberg PD. & Mason PK. (1996). Phlorotannin-protein interactions. Journal of Chemical Ecology, 22: 1877-1899. | ||
In article | View Article PubMed | ||
[23] | Cowan M.M, (1999). Plant products as antimicrobial agents. Clinical Microbiology Reviews, 12: 564-582. | ||
In article | View Article PubMed | ||
[24] | Harborne J.B., Baxter H. & Moss G. P. (1999). Phytochemical dictionary. In A handbook of bioactive compounds from plants. London, Taylor & Francis Eds, 27; 869-877. | ||
In article | |||